Catabolite repression 1985.
The present status of catabolite repression is summarized with respect to the involvement of cyclic AMP and other mediators. A model is presented which may account for the relationship between positive control of gene expression exerted by cAMP and its receptor, CAP, and negative control of catabolite repression mediated by specific metabolites.
Ullmann
A
A
D001419:Bacteria / Q000201:enzymology* / Q000235:genetics; D000242:Cyclic AMP / Q000235:genetics / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000235:genetics; D012321:DNA-Directed RNA Polymerases / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004798:Enzymes / Q000096:biosynthesis / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects; D005947:Glucose / Q000494:pharmacology; D007656:Ketoglutaric Acids / Q000494:pharmacology; D009154:Mutation; D009876:Operon; D011773:Pyruvates / Q000494:pharmacology; D019289:Pyruvic Acid; D011953:Receptors, Cyclic AMP / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects; D014368:Tryptophanase / Q000037:antagonists & inhibitors; D014508:Urea / Q000494:pharmacology; D001616:beta-Galactosidase / Q000037:antagonists & inhibitors
D004269:DNA, Bacterial; D004791:Enzyme Inhibitors; D004798:Enzymes; D007656:Ketoglutaric Acids; D011773:Pyruvates; D011953:Receptors, Cyclic AMP; D019289:Pyruvic Acid; D014508:Urea; D000242:Cyclic AMP; D012321:DNA-Directed RNA Polymerases; D001616:beta-Galactosidase; D014368:Tryptophanase; D005947:Glucose